IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BONO, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.372
AS - Asia 1.893
EU - Europa 1.312
SA - Sud America 192
AF - Africa 65
OC - Oceania 8
Totale 5.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.302
CN - Cina 568
SG - Singapore 557
IT - Italia 552
VN - Vietnam 189
HK - Hong Kong 175
BD - Bangladesh 163
BR - Brasile 149
RU - Federazione Russa 124
GB - Regno Unito 102
NL - Olanda 99
DE - Germania 95
IN - India 83
FI - Finlandia 77
FR - Francia 75
SE - Svezia 66
CA - Canada 46
ID - Indonesia 37
KR - Corea 31
JP - Giappone 28
PL - Polonia 21
AT - Austria 20
IE - Irlanda 20
AR - Argentina 18
ZA - Sudafrica 17
CI - Costa d'Avorio 16
MX - Messico 16
ES - Italia 14
TR - Turchia 14
UA - Ucraina 9
AU - Australia 8
IQ - Iraq 8
PT - Portogallo 6
ZW - Zimbabwe 6
CH - Svizzera 5
EC - Ecuador 5
ET - Etiopia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MY - Malesia 4
NG - Nigeria 4
PE - Perù 4
PK - Pakistan 4
UZ - Uzbekistan 4
BE - Belgio 3
CL - Cile 3
KE - Kenya 3
LV - Lettonia 3
LY - Libia 3
MA - Marocco 3
NO - Norvegia 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IL - Israele 2
KZ - Kazakistan 2
PY - Paraguay 2
RO - Romania 2
UG - Uganda 2
UY - Uruguay 2
VE - Venezuela 2
ZM - Zambia 2
AL - Albania 1
BG - Bulgaria 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MQ - Martinica 1
MT - Malta 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.842
Salva come PNG Salva come JPEG
Città #
Dallas 375
Singapore 287
Ashburn 253
Chicago 194
Milan 182
Los Angeles 165
Hong Kong 146
San Jose 142
Hefei 135
Beijing 85
Salt Lake City 76
New York 62
Council Bluffs 52
Ho Chi Minh City 52
Buffalo 50
Hanoi 49
Santa Clara 43
Bengaluru 42
Helsinki 39
Rome 36
Boardman 35
Munich 35
Southend 34
Tampa 33
Lauterbourg 32
Elk Grove Village 31
Moscow 31
Sterling 30
Jakarta 29
Frankfurt am Main 28
Seoul 24
Phoenix 22
Dublin 20
Guangzhou 20
Lappeenranta 20
São Paulo 20
Chandler 18
Montreal 18
Turku 18
Seattle 17
Abidjan 16
Vienna 16
Shanghai 15
The Dalles 15
Tokyo 15
Turin 15
Warsaw 15
Wilmington 15
Amsterdam 13
Atlanta 13
Da Nang 13
Poplar 13
Miami 12
Boston 11
Haiphong 11
Istanbul 11
Lancaster 11
Toronto 11
Florence 10
Fremont 10
Genoa 10
Houston 10
Las Vegas 10
Memphis 10
Chennai 9
Coventry 9
Dulles 9
London 9
Naples 9
Nuremberg 9
Orem 9
Washington 9
Bologna 8
Cangzhou 8
Düsseldorf 8
Johannesburg 8
Shenzhen 8
Brooklyn 7
Camaiore 7
Columbus 7
Denver 7
Nanjing 7
Perugia 7
San Francisco 7
Coyoacán 6
Detroit 6
Harare 6
Paris 6
Pittsburgh 6
Princeton 6
Quanzhou 6
Stockholm 6
Baghdad 5
Bắc Ninh 5
Fuzhou 5
Hải Dương 5
Mexico City 5
Mumbai 5
Newark 5
Rio de Janeiro 5
Totale 3.530
Salva come PNG Salva come JPEG
Nome #
Inflammation and Intracellular Exposure of Dolutegravir, Darunavir, Tenofovir and Emtricitabine in People living with HIV 469
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 365
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection 294
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 278
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes 263
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19 256
Impairment of platelet function in both mild and severe COVID-19 patients 255
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir 219
Predictors of low ovarian reserve in cART-treated women living with HIV 207
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects 206
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease 202
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms 195
Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects 194
Immunological recovery with BIC/FTC/TAF: CD4 T-cell count and CD4/CD8 ratio as markers of response 189
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV 189
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames? 188
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 182
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients 170
Association between tight junction proteins and cognitive performance in untreated persons with HIV 158
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection 146
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors 145
INFLAMMATORY AND T-CELL HOMEOSTASIS PARAMETERS IN DUAL AND TRIPLE COMBINATION ANTIRETROVIRAL THERAPY (CART) FOR HIV INFECTION 134
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 134
Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV 117
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV 114
Failure of CD4+ T-cell recovery upon virally-effective cART : an enduring gap in the understanding of HIV+ immunological non-responders 112
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 112
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years 104
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19 102
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury 101
Three-Month cART Initiated During Primary HIV Does Not Correct the Structural, Immune, and Microbial Abnormalities within the Gastrointestinal Tract 70
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape 48
Bridging the gap: addressing real-life challenges to the implementation of DTG/3TC in treatment-naive people living with HIV 45
Age and viral replication, not vertical HIV acquisition, drive inflammation and T-cell dysfunction in heavily treatment experienced: data from the Prestigio Registry 36
Astrocyte/monocyte activation and inflammation are associated with asymptomatic neurocognitive impairment in people with HIV on suppressive antiretroviral therapy 1
Totale 6.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022104 7 9 3 10 10 9 9 6 25 3 2 11
2022/2023181 6 3 3 11 16 33 19 9 23 3 35 20
2023/2024411 36 17 20 23 50 40 49 36 11 20 58 51
2024/20251.804 40 91 33 92 61 62 47 60 54 369 281 614
2025/20263.469 257 475 427 348 244 193 400 152 262 227 415 69
Totale 6.000